METiS Pharmaceuticals utilizes AI, machine learning, and quantum simulation to enhance drug delivery and discovery, developing a diverse pipeline of over 10 drugs across various therapeutic areas. The company aims to create optimal therapies for unmet medical needs by leveraging high-throughput experimentation and proprietary technology platforms like AiLNP, AiRNA, and AiTEM.
Funding
$100M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
CCFounders
Product
Problem
Traditional drug discovery and development processes are time-consuming, expensive, and often yield suboptimal therapies due to the complexity of biological systems and the limitations of conventional research methods. Identifying promising drug candidates and optimizing their delivery mechanisms present significant challenges, hindering the development of effective treatments for unmet medical needs.
Solution
METiS Pharmaceuticals is a biotechnology company that leverages artificial intelligence (AI), machine learning, and quantum simulation to accelerate drug discovery and enhance drug delivery. The company's core technology platforms, AiLNP, AiRNA, and AiTEM, integrate AI, quantum chemistry, molecular dynamics, and high-throughput experimentation to identify and optimize drug candidates. METiS develops a diverse pipeline of small molecule and RNA drugs across multiple therapeutic areas through internal development and collaborations with pharmaceutical companies. By applying advanced computational methods and experimental techniques, METiS aims to create best-in-class therapies that address a broad spectrum of diseases.
Target Audience
METiS Pharmaceuticals primarily targets biotechnology and pharmaceutical companies seeking to accelerate their drug discovery programs, as well as academic institutions interested in collaborating on innovative research projects.
Features
- AiLNP platform for AI-driven lipid nanoparticle design and optimization
- AiRNA platform for AI-enhanced RNA drug discovery and development
- AiTEM platform for AI-guided target identification and drug mechanism elucidation
- High-throughput experimentation platform for rapid screening and validation of drug candidates
- Quantum chemistry and molecular dynamics simulations for accurate prediction of molecular properties and interactions
- Proprietary algorithms for predicting drug efficacy, safety, and delivery characteristics